A Study of DS-7011a in Patients With Systemic Lupus Erythematosus

Summary

Systemic lupus erythematosus (SLE) is a systemic chronic autoimmune disease characterized by autoantibody production, inflammation, and tissue damage in multiple organs. Standard of care therapies used to treat SLE are only partially effective and have a wide range of toxicities. There is a need for more effective and safer therapies for patients with SLE.

Timeline

Start

2023-06-07

Primary completion

2025-04-01

Completion

2025-04-01

Drugs

Indications